CrushSCI.com
98.5Average days
101.5Median days
48Fastest days
147Longest days
1322025 publications

Paper Review Records

All Paper Review Records

6 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

49 days

A marker-standardized Melastoma malabathricum leaf extract–poly(lactic- co -glycolic acid) nanocurcumin hydrogel improves repair in splinted diabetic wounds in mice

Authors
Thi Phuong Nhung Tran; Hong Quan Bui; Thi Truc Ly Le; Hoa Hong Chau TruongShow moreShow less
Affiliations
1. Institute of Biotechnology and Food Technology, Industrial University of Ho Chi Minh City , 12 Nguyen Van Bao, Hanh Thong Ward, Ho Chi Minh City 700000 ,Show moreShow less
Source PDF DOI Publisher page
147 days

Nanocarrier-based targeting strategies in epilepsy: addressing pathophysiological barriers

Authors
Abhishek Chauhan; Ankush Kumar; Ankit Awasthi; Rohit BhatiaShow moreShow less
Affiliations
1. Chitkara College of Pharmacy, Chitkara University , Rajpura, Punjab 140401 ,Show moreShow less
Source PDF DOI Publisher page
137 days

A GelMA hydrogel co-loaded with resveratrol, 18-β-glycyrrhetinic acid, and berberine for the combination therapy of infected wounds

Authors
Wenbo Ji; Yaxu Yang; Xinyi Cao; Jie Song; Zhenhai Zhang; Huixia LvShow moreShow less
Affiliations
1. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine , 210023 Nanjing ,; 2. Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University , 211198 Nanjing,Show moreShow less
Source PDF DOI Publisher page
144 days

Farnesoid X receptor blockade attenuates morphological damage, intestinal secretion, and prevents mucus loss induced by SARS-CoV-2 spike protein in the mouse intestine

Authors
André Luis Fernandes Lopes; Andreza Ketly da Silva Araújo; Letícia de Sousa Chaves; Esley da Silva Santos; Antonio Carlos Pereira de Oliveira; Katriane Carvalho da Silva; Gabriella Pacheco; Marcelo Biondaro Gois; Lucas Antonio Duarte Nicolau; Jand Venes Rolim MedeirosShow moreShow less
Affiliations
1. Laboratory of Inflammation and Translational Gastroenterology (LIGAT), Post-graduation Program in Biotechnology (PPGBIOTEC), Parnaíba Delta Federal University , Av. São Sebastião, 2819, Parnaíba, PI 64202-020 ,; 2. Post-Graduation Program in Biosciences and Health, Federal University of Rondonópolis , Av. dos Estudantes, 5055 (Faculdade de Ciências da Saúde), Cidade Universitária, Rondonópolis, MT 78736-900 ,Show moreShow less
Source PDF DOI Publisher page
66 days

Norisoboldine suppresses epithelial–mesenchymal transition in colorectal cancer by simultaneously inhibiting the CXCR4/CXCR7 chemokine receptors and the JAK/STAT3 signaling pathway

Authors
Na Young Kim; Yejin Hong; Seung Ho Baek; Dongwoo Nam; Ducdat Le; Mina Lee; Jae-Young Um; Kwang Seok AhnShow moreShow less
Affiliations
1. Department of Science in Korean Medicine, Kyung Hee University , 24 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447 ,; 2. Department of Acupuncture and Moxibustion, Kyung Hee University, Korean Medicine Hospital , Seoul 02447 ,; 3. College of Korean Medicine, Dongguk University , 32 Dongguk-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 10326 ,; 4. Department of Acupuncture and Moxibustion, College of Korean Medicine, Kyung Hee University , Seoul 02447 ,; 5. College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University , 255 Jungangno, Suncheon, Jeonnam 57922 ,; 6. Department of Natural Cosmetics Science and AI Digital Bioscience Research Institute, Graduate School, Sunchon National University , 255 Jungangno, Suncheon, Jeonnam 57922 ,; 7. Kyung Hee Institute of Convergence Korean Medicine, Kyung Hee University , 24 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447 ,Show moreShow less
Source PDF DOI Publisher page
48 days

3D-printed long-acting 5-fluorouracil implant to prevent conjunctival fibrosis in glaucoma

Authors
Nicole Ioannou; Jinyuan Luo; Mengqi Qin; Matteo Di Luca; Essyrose Mathew; Aristides D Tagalakis; Dimitrios A Lamprou; Cynthia Yu-Wai-ManShow moreShow less
Affiliations
1. Faculty of Life Sciences & Medicine, King’s College London, London, UK; 2. Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China; 3. School of Pharmacy, Queen’s University Belfast, Belfast, UK; 4. Department of Biology, Edge Hill University, Ormskirk, UKShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF PHARMACY AND PHARMACOLOGY take to review a manuscript?

As of 2026-11-19, CrushSCI has 6 complete review records for JOURNAL OF PHARMACY AND PHARMACOLOGY. The fastest paper went from submission to acceptance in 48 days (3D-printed long-acting 5-fluorouracil implant to prevent conjunctival fibrosis in glaucoma, received 2022-10-25, accepted 2022-12-12); the slowest took 147 days. The average is 98.5 days and the median is 101.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.